UNICEF has announced the launch of a COVID-19 vaccine market dashboard. It is an interactive tool that provides a regularly updated overview of the global research and development.
COVID-19 Vaccine: Where Do We Stand Now?
COVID-19: The biggest challenge with the pandemic lies in not only developing a successful vaccine but also producing it in quantities necessary to provide immunity to all citizens. Competition is already emerging over who will have access once a vaccine is ready.
COVID-19: The biggest challenge with the pandemic lies in not only developing a successful vaccine but also producing it in quantities necessary to provide immunity to all citizens. Competition is already emerging over who will have access once a vaccine is ready.
‘UNICEF has announced the launch of a COVID-19 vaccine market dashboard. It is an interactive tool that provides a regularly updated overview of the global research and development.’
The dashboard provides a regularly updated overview of the global research and development pipeline, the projected production capacity, publicly announced bilateral and multilateral supply agreements, as well as reported price points, Xinhua news agency quoted the UNICEF as saying in a statement on Monday. In 2021, the dashboard will provide an update on the status of procurement by the UNICEF and other buyers participating in the COVAX Facility.
It will also track the status of deliveries by the UNICEF and other participating national and institutional buyers, it said.
Clinical Trials of Therapeutics for COVID-19: Current Status
Clinical trials that are well-designed, well-planned and conducted in a timely manner will ensure the development of a safe and effective drug for the treatment of COVID-19 sooner than later.
Clinical trials that are well-designed, well-planned and conducted in a timely manner will ensure the development of a safe and effective drug for the treatment of COVID-19 sooner than later.
Advertisement
Phase II Trial of Oxford COVID-19 Vaccine Begins
The phase II trials of the Oxford vaccine for Coronavirus began on Wednesday with 2 volunteers receiving the first dose in Pune.
The phase II trials of the Oxford vaccine for Coronavirus began on Wednesday with 2 volunteers receiving the first dose in Pune.
COVID-19 Vaccine Development may Take 18 Months
Vaccine For COVID-19 could take at least 12-18 months to develop, according to a new report from the New York Times.
Vaccine For COVID-19 could take at least 12-18 months to develop, according to a new report from the New York Times.
